Status:
RECRUITING
Thoracic Specimen Registry
Lead Sponsor:
Mayo Clinic
Conditions:
Thoracic Diseases
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other cancers and diseases of the thorax by deve...
Detailed Description
The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clin...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject must be \> 18 years of age
- Presumed or known or screening of Thoracic Diseases (which includes but not limited to the following: thoracic neoplasms (masses/nodules) malignant or benign, interstitial lung diseases (ILD), chronic obstructive pulmonary disease (COPD), thoracic infections, thoracic malignancies metastatic to other organs, other cancers metastatic to the thoracic cavity.
Exclusion
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT04118660
Start Date
March 1 2017
End Date
January 1 2028
Last Update
January 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905